2-27444503-A-G
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_015662.3(IFT172):āc.5179T>Cā(p.Cys1727Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000384 in 1,613,514 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ā ).
Frequency
Consequence
NM_015662.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250598Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135392
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461356Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 726956
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74340
ClinVar
Submissions by phenotype
Short-rib thoracic dysplasia 10 with or without polydactyly Pathogenic:2
A heterozygous missense variant, NM_015662.1(IFT172):c.5179T>C, has been identified in exon 48 of 48 of the IFT172 gene. The variant is predicted to result in a major amino acid change from cysteine to arginine at position 1727 of the protein (NP_056477.1(IFT172):p.(Cys1727Arg)). The cysteine at this position has moderate conservation (100 vertebrates, UCSC), but is not located within a well established functional domain. In silico predictions for this variant are consistently pathogenic (Polyphen, SIFT, CADD, Mutation Taster). This variant is present in the gnomAD database at a frequency of 0.0014% (4 heterozygotes and 0 homozygotes). It has been previously described as pathogenic in multiple cases and segregated with the disease in one family (Halbritter J. et al. (2013), McIerney A. et al. (2014)). Additionally, examination of cultured patient fibroblast showed significant decrease in adenylyl cyclase III (Halbritter J. et al. 2013). Based on the information available at the time of curation, this variant has been classified as PATHOGENIC. -
- -
Short-rib thoracic dysplasia 10 with or without polydactyly;C4225342:Retinitis pigmentosa 71 Pathogenic:1
This sequence change replaces cysteine, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 1727 of the IFT172 protein (p.Cys1727Arg). This variant is present in population databases (rs149614625, gnomAD 0.003%). This missense change has been observed in individual(s) with skeletal ciliopathies and Mainzer-Saldino syndrome (PMID: 24140113, 25664603). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 97022). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt IFT172 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
IFT172-related disorder Pathogenic:1
The IFT172 c.5179T>C variant is predicted to result in the amino acid substitution p.Cys1727Arg. This variant was reported in multiple patients with asphyxiating thoracic dystrophy and Mainzer-Saldino syndrome (Halbritter et al. 2013. PubMed ID: 24140113; Lucas-Herald et al. 2015. PubMed ID: 25664603). This variant is reported in 0.0031% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -
Short-rib thoracic dysplasia 10 with or without polydactyly;C4225342:Retinitis pigmentosa 71;C4310707:Bardet-Biedl syndrome 20 Pathogenic:1
- -
Retinitis pigmentosa Pathogenic:1
The p.Cys1727Arg variant in IFT172 was identified in an individual with Retinitis pigmentosa, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Pierce lab (https://oculargenomics.meei.harvard.edu/labs/pierce-lab/lab-members/). Through a review of available evidence we were able to apply the following criteria: PM2, PP3, PS3, PP1, PM3. Based on this evidence we have classified this variant as Pathogenic. If you have any questions about the classification please reach out to the Pierce Lab. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at